Congratulations to Guillermo, Eduardo, Raquel and Conchita!
We have filed a European patent application to protect a new family of copper-based compounds that could be used in cancer treatment. So far, the studies we’ve conducted show that these new compounds display significant activity in animal models of breast, cervical, and pancreatic cancer.
Traditionally, cancer treatments have been associated with organic compounds. However, some current drugs already incorporate metals into their structure, although there are concerns about possible side effects. In this context, we believe copper could become an innovative and potentially safer alternative, opening the door to therapies with new mechanisms of action.
The project has been funded by the Ministerio de Ciencia e Innovación and the Agencia Estatal de Investigación through project PDC2022-133376-I00, within the framework of the Recovery, Transformation and Resilience Plan and financed by the European Union – NextGenerationEU.
Herrera-OrganoCatalisis Asimétrica Group 